End-of-day quote
Taipei Exchange
23:00:00 30/06/2024 BST
5-day change
1st Jan Change
78.5
TWD
-1.75%
+27.64%
+91.46%
Sofiva Genomics Co.,Ltd. Announces Cash Dividend for the Year Ended December 31, 2021
March 23, 2022 at 06:52 am
Sofiva Genomics Co.,Ltd. announced an appropriations of earnings in cash dividend to shareholders is TWD 2 for the year ended December 31, 2021.
Sofiva Genomics Co.,Ltd. Announces Adjusted Rate on Cash Dividend, Payable on July 26, 2024
06-04
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-15
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
03-18
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-09
CI
Sofiva Genomics Co.,Ltd. Announces Resignation of Su,Yining as CEO
11-07
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
10/08/23
CI
Sofiva Genomics Co.,Ltd. Declares Cash Dividend, Payable on July 31, 2023
14/06/23
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
12/05/23
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
31/03/23
CI
Sofiva Genomics Co.,Ltd. Approves Cash Dividend for the Year Ended December 31, 2022
22/03/23
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
07/11/22
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
04/08/22
CI
Sofiva Genomics Co.,Ltd. Announces Cash Dividend, Payable on July 28, 2022
16/06/22
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
04/05/22
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
24/03/22
CI
Sofiva Genomics Co.,Ltd. Announces Cash Dividend for the Year Ended December 31, 2021
23/03/22
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
11/11/21
CI
Sofiva Genomics Co.,Ltd. Approves the Election of Board of Directors
18/08/21
CI
Sofiva Genomics Co.,Ltd. Announces Change of the Members of the Third Audit Committee
18/08/21
CI
Sofiva Genomics Co.,Ltd. Announces Change of Members of the Third Remuneration Committee
18/08/21
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
12/08/21
CI
Sofiva Genomics Co.,Ltd. Announces Cash Dividend, Payable on August 6, 2021
23/06/21
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
12/05/21
CI
Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
28/03/21
CI
Sofiva Genomics Co.,Ltd. Approves Dividend from 2020/01/01~2020/12/31
24/03/21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Sofiva Genomics Co Ltd is a Taiwan-based company mainly engaged in provision of deoxyribonucleic acid (DNA) testing services. The Company's DNA testing services mainly contain reproductive medicine testing, pregnant women testing, newborn testing, rare disease genetic testing, personalized genetic testing, cancer genetic testing, and genetic counseling services. Reproductive Medicine testing is pre-implantation genetic diagnosis for embryos. Pregnant women testing services predict the occurrence of preeclampsia and provide prenatal diagnosis. Neonatal testing services provide neonatal hearing loss genetic test, respiratory distress syndrome test, congenital cytomegalovirus infection test service. Personalized genetic testing services includes human papilloma virus screening, paternity testing, telomere testing, chronic disease and cardiovascular disease and other genetic research. Cancer genetic testing services is applied to cancer patients.
More about the company
1st Jan change
Capi.
+91.46% 52.54M -42.65% 7.8B +4.47% 3.53B -0.86% 2.24B -26.79% 1.84B -22.46% 1.66B +5.95% 951M +28.17% 811M -7.86% 670M -26.53% 533M
Bio Diagnostics & Testing
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1